Holen Sie sich die Stockscreener-App
482.79
0.12%
-0.57
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ISRG?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$483.36
Offen:
$483.22
24-Stunden-Volumen:
1.61M
Relative Volume:
0.94
Marktkapitalisierung:
$173.13B
Einnahmen:
$9.15B
Nettoeinkommen (Verlust:
$2.61B
KGV:
67.33
EPS:
7.17
Netto-Cashflow:
$1.99B
1W Leistung:
-2.83%
1M Leistung:
-11.33%
6M Leistung:
-18.29%
1J Leistung:
+10.23%
1-Tages-Spanne:
$477.45
$486.51
1-Wochen-Bereich:
$473.24
$503.21
52-Wochen-Spanne:
$425.00
$616.00
Intuitive Surgical Inc Stock (ISRG) Company Profile
Firmenname
Intuitive Surgical Inc
Sektor
Telefon
(408) 523-2100
Adresse
1020 KIFER ROAD, SUNNYVALE
Vergleichen Sie ISRG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
482.97 | 173.19B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
178.02 | 50.55B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.87 | 43.46B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
284.51 | 40.94B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
238.84 | 17.20B | 2.90B | 467.20M | 306.90M | 6.37 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-23 | Herabstufung | Erste Group | Buy → Hold |
| 2025-06-09 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2025-06-05 | Hochstufung | Erste Group | Hold → Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Bestätigt | Citigroup | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-11-17 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-19 | Bestätigt | BTIG Research | Buy |
| 2023-04-19 | Bestätigt | BofA Securities | Buy |
| 2023-04-19 | Bestätigt | Citigroup | Buy |
| 2023-04-19 | Bestätigt | Evercore ISI | In-line |
| 2023-04-19 | Bestätigt | JP Morgan | Overweight |
| 2023-04-19 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-19 | Bestätigt | Raymond James | Outperform |
| 2023-04-19 | Bestätigt | Stifel | Buy |
| 2023-04-19 | Bestätigt | Truist | Buy |
| 2023-04-19 | Bestätigt | Wells Fargo | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-23 | Eingeleitet | William Blair | Outperform |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Neutral |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-31 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Herabstufung | Redburn | Buy → Neutral |
| 2022-01-21 | Bestätigt | BTIG Research | Buy |
| 2022-01-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-01-21 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-21 | Bestätigt | Evercore ISI | In-line |
| 2022-01-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Bestätigt | Piper Sandler | Neutral |
| 2022-01-21 | Bestätigt | Raymond James | Outperform |
| 2022-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2022-01-21 | Bestätigt | Stifel | Buy |
| 2022-01-21 | Bestätigt | UBS | Neutral |
| 2022-01-21 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-10 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-07-21 | Bestätigt | BofA Securities | Neutral |
| 2021-07-21 | Bestätigt | Citigroup | Buy |
| 2021-07-21 | Bestätigt | JP Morgan | Overweight |
| 2021-07-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Bestätigt | Piper Sandler | Neutral |
| 2021-07-21 | Bestätigt | SVB Leerink | Mkt Perform |
| 2021-07-21 | Bestätigt | Stifel | Buy |
| 2021-07-21 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Bestätigt | Wells Fargo | Overweight |
| 2021-07-14 | Bestätigt | Goldman | Buy |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Eingeleitet | Argus | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-07-20 | Bestätigt | Bernstein | Outperform |
| 2020-04-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Herabstufung | CFRA | Hold → Sell |
| 2020-04-17 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Bestätigt | Wells Fargo | Outperform |
| 2019-11-21 | Eingeleitet | Oppenheimer | Perform |
| 2019-07-19 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-22 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-02 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-31 | Bestätigt | Piper Jaffray | Overweight |
| 2018-10-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
Alle ansehen
Intuitive Surgical Inc Aktie (ISRG) Neueste Nachrichten
Robotic Cardiology Surgery Market Generated Opportunities, - openPR.com
ISRG's Ion Platform Sees Uptick in Utilization, Eyes Efficiency - sharewise.com
RBC Raises Intuitive Surgical (ISRG) Price Target After Strong Earnings Beat - MSN
Intuitive Surgical’s $1.2B Volume Ranks 60th as Analysts Hike Targets and Institutions Pile In - AInvest
Intuitive Surgical, Inc. (ISRG) Installs 395 da Vinci Systems in Q2, Forecasts 17% Procedure Growth - MSN
How does Intuitive Surgical Inc. generate profit in a changing economyCapitalize on market shifts with expert advice - jammulinksnews.com
What makes Intuitive Surgical Inc. stock price move sharplyHigh-yield trading alerts - Jammu Links News
The Best Growth Stocks I'd Buy Right Now - The Globe and Mail
What is Intuitive Surgical Inc. company’s growth strategyRapid-fire capital growth - jammulinksnews.com
What are Intuitive Surgical Inc. company’s key revenue driversAchieve rapid financial growth with expert help - Jammu Links News
Intuitive Surgical Surges, but Are There More Roadblocks Ahead? - AOL.com
When is Intuitive Surgical Inc. stock expected to show significant growthMarket-leading profit generation - Jammu Links News
Should I hold or sell Intuitive Surgical Inc. stock in 2025Capitalize on strategic market trends - jammulinksnews.com
2 Monster Stocks to Hold for the Next 5 Years - The Motley Fool
Intuitive Surgical Surges 0.42% on Strong Q2 Results as $1.43 Billion Volume Ranks 64th in Market Activity - AInvest
Intuitive Surgical’s New Study: A Closer Look at the Ion Endoluminal System - TipRanks
United States Surgical Robots Market Competition, Forecast - GlobeNewswire
United States Surgical Robots Market Competition, Forecast & Opportunities Report 2025-2030, with Medtronic, Intuitive Surgical, Stryker, Medrobotics, TransEnterix, Think Surgical, Accuray, and More - Yahoo Finance
Stock Analysis | Intuitive Surgical OutlookMixed Signals Amid Earnings Volatility - AInvest
Intuitive’s da Vinci 5 surgical system receives CE mark approval - Home | Digital Health
11 Best Medical Stocks to Buy According to Analysts - Insider Monkey
Intuitive Surgical's $1.26B Volume Spike Propels It to 97th Rank Amid Clinical Trial Updates and Market Momentum Plays - AInvest
Robotic Surgery Co.'s Antitrust Appeal Backed At 9th Circ. - Law360
How volatile is Intuitive Surgical Inc. stock compared to the marketBreakout Stocks Signals Backed By Experts - jammulinksnews.com
LivsMed Debuts New Robotic System With Telesurgery Capabilities - Medical Product Outsourcing
Intuitive Surgical Soars on Solid Financial Results, Boosted by Robotic Surgery Adoption - AInvest
Intuitive Surgical (ISRG) Soared on Solid Financial Results - Insider Monkey
North America Microsurgery Robot Market Size & Growth, 2033 - Market Data Forecast
Intuitive Surgical Ranks 115th in $880M Trading Volume as Robotic Growth and Patent Approval Drive Short-Term Gains - AInvest
Intuitive Surgical, Inc. (ISRG): “I Really Like” It, Says Jim Cramer - MSN
Lung Cancer Surgery Market to Reach USD 2.64 Billion by 2035, - openPR.com
Jim Cramer on Intuitive Surgical: “I’m Inclined to Recommend the Stock” - Insider Monkey
5 Must-Read Analyst Questions From Intuitive Surgical’s Q2 Earnings Call - Yahoo Finance
Jim Cramer on Intuitive Surgical: "I’m Inclined to Recommend the Stock" - Yahoo Finance
Intuitive Surgical’s SWOT analysis: robotic surgery leader faces tariff headwinds - Investing.com
Intuitive Surgical’s SWOT analysis: robotic surgery leader faces tariff headwinds By Investing.com - Investing.com South Africa
One Buy-Rated Stock With An Unbreakable Moat That You Can’t Ignore - Barchart.com
HRH heralds arrival of robotic-assisted surgery - The Daily World
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
ISRG's Gross Margin Falls on Product Transition and Trade Pressures - Yahoo Finance
Intuitive Surgical's Insider Selling: A Signal or a Strategy in a Robotic Surge? - AInvest
Intuitive Surgical Reports 21.4% YoY Revenue Growth in Q1 2025, Expands Installed Base and Manufacturing Capacity - AInvest
Intuitive surgical gains momentum from procedure growth - MarketScreener
How strong is Intuitive Surgical Inc. company’s balance sheetAccess powerful market insights for free - jammulinksnews.com
Intuitive Surgical, Inc. (NASDAQ:ISRG) Q2 2025 Earnings Call Transcript - MSN
Intuitive Surgical (ISRG) Shares Dip Despite Strong Q2 Performan - GuruFocus
12 out of 12 healthcare firms top revenue estimates this week: Earnings Scorecard - Seeking Alpha
Intuitive Surgical’s Strong Performance and Growth Potential Reinforce Buy Rating - TipRanks
Finanzdaten der Intuitive Surgical Inc-Aktie (ISRG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):